You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

elderly newly diagnosed

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Newly Diagnosed Multiple Myeloma Trial in New York (Daratumumab, Bortezomib, Lenalidomide)

Recruiting
  • Newly Diagnosed Multiple Myeloma
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Dec 29, 2022

Lymphoma, Mantle-Cell Trial in Shanghai (Zanubrutinib, Rituximab, Bendamustin)

Not yet recruiting
  • Lymphoma, Mantle-Cell
  • Shanghai, Shanghai, China
    Ruijin Hospital
Nov 14, 2023

B Acute Lymphoblastic Leukemia Trial in Suzhou (Blinatumomab)

Recruiting
  • B Acute Lymphoblastic Leukemia
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University, Jiangsu Ins
Nov 1, 2022

Aplastic Anemia Trial in Beijing (Ciclosporin, Avatrombopag, Anti-Human Thymocyte Immunoglobulin, Rabbit)

Not yet recruiting
  • Aplastic Anemia
  • Beijing, China
    Peking union medical college hospital
Aug 16, 2023

Acute Myeloid Leukemia Trial in Tianjin (Different induction chemo regimens)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Different induction chemotherapy regimens
  • Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Sep 27, 2023

Multiple Myeloma Trial (Teclistamab, Daratumumab, Lenalidomide)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Oct 6, 2022

HER2 Negative Breast Cancer Not Immediately Operated Trial (Ribociclib Oral Tablet)

Not yet recruiting
  • HER2 Negative Breast Cancer Not Immediately Operated
  • Ribociclib Oral Tablet
  • (no location specified)
Dec 16, 2022

Diffuse Large B Cell Lymphoma Trial in Busan (PrednisoLONE 50 MG)

Completed
  • Diffuse Large B Cell Lymphoma
  • PrednisoLONE 50 MG
  • Busan, Sue-gu, Korea, Republic of
    Kosin University Gospel Hospital
Mar 31, 2022

Leukemia, Myeloid, Acute, AML Stage, Adult Trial in Xiamen (Venetoclax Combining Chidamide and Azacitidine (VCA) regimen

Not yet recruiting
  • Leukemia, Myeloid, Acute
  • AML Stage, Adult
  • Venetoclax Combining Chidamide and Azacitidine (VCA) regimen followed by dicitabine combined with liposome mitoxantrone, cytarabine, and G-CSF (D-MAG) regimen
  • Xiamen, Fujian, China
    Bing Xu
Oct 29, 2022

Diffuse Large B Cell Lymphoma Trial in Hangzhou (Rituximab, Lenalidomide, Zanubrutinib and RCHOP)

Not yet recruiting
  • Diffuse Large B Cell Lymphoma
  • Rituximab, Lenalidomide, Zanubrutinib and RCHOP
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Mar 21, 2022

Diffuse Large B Cell Lymphoma Trial in Wenzhou (Zanubrutinib+Rituximab+Lenalidomide, RCHOP/RCDOP)

Recruiting
  • Diffuse Large B Cell Lymphoma
  • Wenzhou, Zhejiang, China
    First Affiliated Hospital of Wenzhou Medical University
Jun 20, 2022

Multiple Myeloma, Myeloma Trial in Poitiers (Isatuximab, Lenalidomide, Bortezomib)

Active, not recruiting
  • Multiple Myeloma
  • Myeloma
  • Poitiers, France
    CHU Poitiers
Sep 5, 2022

Multiple Myeloma Trial in Torino (Lenalidomide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Torino, Italy
    FO.NE.SA.Onlus
Mar 24, 2022

Acute Myeloid Leukaemia; MDS;Chronic Myelomonocytic Leukemia Trial in Shenzhen (Azacytidine, HAG Regimen, Azacytidine)

Recruiting
  • Acute Myeloid Leukaemia; Myelodysplastic Syndromes;Chronic Myelomonocytic Leukemia
  • Shenzhen, Guangdong, China
    Shenzhen Second People's Hospital
Mar 14, 2022

AML Trial (APVO436)

Withdrawn
  • AML
  • APVO436
  • (no location specified)
Nov 29, 2021

Acute Myeloid Leukemia Trial in Aurora (Azacitidine, Venetoclax)

Recruiting
  • Acute Myeloid Leukemia
  • Aurora, Colorado
    Universtiy of Colorado Hospital
Aug 22, 2022

Acute Myeloid Leukemia Trial (Sulfasalazine)

Not yet recruiting
  • Acute Myeloid Leukemia
  • (no location specified)
Oct 11, 2022

CNS Lymphoma Trial in Aarhus (Immunochemo)

Completed
  • Central Nervous System Lymphoma
  • Aarhus, Denmark
    Elisa Jacobsen Pulczynski
Aug 3, 2022

Multiple Myeloma Trial (RP followed by MPR)

Active, not recruiting
  • Multiple Myeloma
  • RP followed by MPR
  • (no location specified)
Mar 24, 2022

Glioblastoma Multiforme Trial in Calgary, Edmonton (Biomarker based treatment (Temozolomide monotherapy or Radiotherapy

Recruiting
  • Glioblastoma Multiforme
  • Biomarker based treatment (Temozolomide monotherapy or Radiotherapy monotherapy)
  • Chemo-Radiotherapy consisting of 40 Gy in 15 daily fractions with concurrent temozolomide.
  • Calgary, Alberta, Canada
  • +1 more
Jun 24, 2022

Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Houston (Decitabine and

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Apr 1, 2022

Primary Immune Thrombocytopenia Trial (2.5mg/d Hetrombopag)

Not yet recruiting
  • Primary Immune Thrombocytopenia
  • 2.5mg/d Hetrombopag
  • (no location specified)
Mar 28, 2022

Glioblastoma Multiforme Trial in Australia, United States (Nivolumab, Temozolomide)

Active, not recruiting
  • Glioblastoma Multiforme
  • Durham, North Carolina
  • +19 more
Jul 14, 2022

Mantle Cell Lymphoma Trial in Seoul (RB/RBAC alternating, RB)

Not yet recruiting
  • Mantle Cell Lymphoma
  • RB/RBAC alternating
  • RB
  • Seoul, Gangnam-Gu, Korea, Republic of
    Samsung Medical Center
Apr 18, 2022

Multiple Myeloma Trial in Busan (Lenalidomide, Dexamethasone)

Recruiting
  • Multiple Myeloma
  • Busan, Western, Korea, Republic of
    Kosin University Gospel Hospital
Mar 31, 2022